$3.8 billion worth of global neurovascular device market size

CHICAGO, Jan. 19, 2023 (GLOBE NEWSWIRE) — According to new market research report “Neurovascular device market Growth by Size, Product (Embolization (Coils, Flow Diverters), Stents, Balloon Occlusion Devices, Clot Retrievers, Microcatheters), Pathology (Stroke, Aneurysm, CAS, AVM) Users (Hospitals, ASC) – 2026 world forecast by year“, The market size of neurovascular devices is expected to grow from an estimated USD 2.5 billion in 2021 to USD 3.8 billion in 2026, at a CAGR of 8.6%.

View detailed TOC atNeurovascular device market“
261 – Table
49 – numbers
281 – page

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=847

Report scope:

Sample page request: https://www.marketsandmarkets.com/requestsampleNew.asp?id=847

Growing patient populations, ongoing product development and commercialization, favorable healthcare reimbursement, expansion of healthcare infrastructure across emerging markets, increasing market demand for effective neurovascular devices, increasing demand for neurovascular treatments Increasing research in the field, increasing demand for minimally invasive neurosurgical procedures, and growing awareness of neurosurgeons about minimally invasive surgery will lead to high growth of the neurovascular devices/interventional neurology market during the forecast period. outlook.

By type, the aneurysm coiling & embolic devices product segment is further segmented into embolic coils, flow diversion devices, and liquid embolic agents. The Aneurysm Coiling and Embolization Devices segment will hold the largest share of the neurovascular devices/interventional neurology market in 2021 due to growth in research activity to establish the clinical efficacy of embolization products in neurovascular treatments. , and the market is expanding. Adoption of innovative neurosurgical techniques (such as new flow diverters and liquid embolic agents for the treatment of complex aneurysms) and increased adoption of endovascular coils in aneurysm treatment (an important Awareness and availability of extensive clinical data supporting safety and clinical) efficacy of endovascular coils).

Talk to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=847

Geographic Growth Scenario:

North America is estimated to be the largest market for neurovascular devices/interventional neurology during the forecast period. The North American neurovascular device/interventional neurology market is driven primarily by increasing patient populations with neurovascular disease, large reimbursements available in the US for neurosurgical procedures, and interventional neurology devices is being driven by factors such as increasing awareness among neurosurgeons about the benefits of Also, ongoing government initiatives to modernize and expand healthcare infrastructure. Moreover, adoption of these devices is increasing due to falling product prices, thereby further supporting market growth in the region.

Major Players:

Major Players in the Neurovascular Devices Market are Johnson & Johnson (US), Medtronic PLC (Ireland), Stryker Corporation (US), Terumo Corporation (Japan), Penumbra, Inc. (US), MicroPort Scientific Corporation (China), Kaneka. Corp. (Japan), Integer Holdings Corporation, BALT (France), Perflow Medical (Israel), Phenox GmbH (Germany), Sensome (France), Evasc (Canada), Rapid Medical (Israel), Asahi Intecc Co. Ltd (Japan) ) ), Acandis GmbH (Germany), Medikit Co. Ltd (Japan), Imperative Care (USA), Lepu Medical (China), Cerus Endovascular (USA), etc.

Browse Adjacent Markets: Medical device market Research reports and consulting

See related report:

Cardiac intervention device market

Vascular closure device market

Neuromodulation market

Peripheral vascular device market

inflation device market